The onset of this pandemic has put pharma-biopharma enterprises in various nations under tremendous financial duress. RWE technologies have proven to be highly useful in this area, as they enable industrial and academic researchers to monitor patients utilising digitally linked platforms while also assisting in the organisation and evaluation of clinical data for regulatory filings. As per Delvens market analysis report, global Real-World Evidence (RWE) Solutions market size is forecasted to reach a CAGR of 14.6% from 2021 to 2028.